Parmax Pharma Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
---|---|---|---|---|---|
Debt-Equity Ratio | 1.91 | 0.89 | 0.94 | 1.02 | 1.11 |
Long Term Debt-Equity Ratio | 1.75 | 0.76 | 0.85 | 0.96 | 1.06 |
Current Ratio | 0.80 | 0.95 | 0.89 | 0.88 | 0.89 |
Fixed Assets | 0.58 | 0.86 | 1.09 | 2.05 | 2.51 |
Inventory | 3.30 | 4.31 | 5.37 | 7.86 | 6.26 |
Debtors | 9.06 | 23.72 | 15.67 | 10.59 | 9.41 |
Interest Cover Ratio | -8.13 | 1.14 | 1.77 | 4.24 | 6.62 |
PBIDTM (%) | -30.05 | 14.85 | 14.41 | 13.44 | 8.93 |
PBITM (%) | -45.52 | 2.66 | 3.84 | 6.03 | 4.11 |
PBDTM (%) | -35.66 | 12.45 | 12.27 | 12.02 | 8.31 |
CPM (%) | -36.83 | 11.54 | 11.34 | 10.27 | 6.88 |
APATM (%) | -52.31 | -0.65 | 0.77 | 2.86 | 2.05 |
ROCE (%) | 0.00 | 3.76 | 6.04 | 14.26 | 8.40 |
RONW (%) | 0.00 | -1.69 | 2.38 | 13.79 | 8.88 |